makes sense but we should probably confirm with uptodate or another resource
Per UpToDate:
• Within the United States, approach to treatment of leprosy aligns with the United States National Hansen’s Disease Program (NHDP), as follows:
-For patients with tuberculoid (paucibacillary [PB]; TT, BT) disease, we suggest treatment with dapsone and daily rifampin for 12 months (Grade 2C).
-For patients with lepromatous (multibacillary [MB]; LL, BL, BB) disease, we suggest treatment with dapsone, daily rifampin, and clofazimine for 24 months (Grade 2C).
• Outside the United States, countries follow the World Health Organization (WHO) approach, as follows:
-For patients with tuberculoid (PB; TT, BT) disease, treatment consists of dapsone, monthly rifampin, and clofazimine for 6 months.
-For patients with lepromatous (MB; LL, BL, BB) disease, treatment consists of dapsone, monthly rifampin, and clofazimine for 12 months.